Immune Analysis of Endometrial Cancer

Characterization of tumor-infiltrating lymphocytes (TILs) in endometrial cancer - TIL-EC

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060677

Enrollment

Registered

2026-04-01

Start date

2026-04-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Patients who visit the institution between the date of approval by the head of the research institution and March 31, 2027. 2. Patients with a diagnosis or radiological suspicion of endometrial cancer, who are in good general condition and scheduled for tissue collection, such as via surgical resection. 3. Patients from whom written informed consent for study participation can be obtained based on their own free will. 4. Patients aged 18 years or older at the time of providing consent. No upper age limit is set as long as criterion 4 is met.

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or may be pregnant. 2. Patients judged by their primary physician to be unsuitable for tissue collection or study participation.

Design outcomes

Primary

Measure	Time frame
Flow cytometric analysis of TILs	—

Secondary

Measure	Time frame
1. Protein analysis of TIL culture supernatants via ELISA and other methods 2. Immunohistochemical analysis of tumor tissues 3. Flow cytometric analysis of PBMCs and body cavity fluids	—

Countries

Japan

Contacts

Public ContactYosuke Togashi

Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences

ytogashi@okayama-u.ac.jp0862357390

Outcome results